Bromide

Bromide

SCHEMBL1593624

Br.COc1ccccc1CN[C@@H]1CCc2ccccc2[C@@H]1Cc1ccc(F)cc1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 1/20 0.48
KDM4E B2RXH2 1/20 0.45
KDM1A O60341 4/20 0.44
MAOA P21397 4/20 0.44
MAOB P27338 3/20 0.44
KMT2A Q03164 4/20 0.43
TACR1 P25103 5/20 0.42
PIN1 Q13526 1/20 0.41
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
HTR2B P41595 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL1593626 1.00 NPY5R (0.48) NPY5RKDM4EKDM1AMAOAMAOB
Bromide SCHEMBL1593628 1.00 NPY5R (0.48) NPY5RKDM4EKDM1AMAOAMAOB
SCHEMBL4292821 0.99 NPY5R (0.48) NPY5RKDM4EKDM1AMAOAMAOB
SCHEMBL4292822 0.99 NPY5R (0.48) NPY5RKDM4EKDM1AMAOAMAOB
SCHEMBL4287875 0.99 NPY5R (0.48) NPY5RKDM4EKDM1AMAOAMAOB
SCHEMBL4287872 0.99 NPY5R (0.48) NPY5RKDM4EKDM1AMAOAMAOB
SCHEMBL4287876 0.99 NPY5R (0.48) NPY5RKDM4EKDM1AMAOAMAOB
Oxalic Acid SCHEMBL1593708 0.93 KMT2A (0.51) NPY5RKDM4EKDM1AMAOAMAOB
Oxalic Acid SCHEMBL1593705 0.93 KMT2A (0.51) NPY5RKDM4EKDM1AMAOAMAOB
Oxalic Acid SCHEMBL1593706 0.93 KMT2A (0.51) NPY5RKDM4EKDM1AMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1119543-B1 N-ARALKYLAMINOTETRALINS AS LIGANDS FOR THE NEUROPEPTIDE Y Y5 RECEPTOR ORTHO MCNEIL PHARM INC (US) 2004-12-15 EP claimed
US-6201025-B1 FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS ORTHO-MCNEIL PHARMACEUTICAL, INC. 2001-03-13 US claimed
US-7919329-B2 Using proopiomelanocortin neuronal regulatory sequences to identify agents that affects caloric intake, energy expenditure, appetite or food intake; treating eating disorders and/or cachexia OREGON HEALTH & SCIENCE UNIVERSITY (US) 2011-04-05 US disclosed
US-7459432-B2 Modification of feeding behavior IMPERIAL COLLEGE INNOVATIONS LTD. (GB) 2008-12-02 US disclosed
US-20080213803-A1 ASSESSMENT OF NEURONS IN THE ARCUATE NUCLEUS TO SCREEN FOR AGENTS THAT MODIFY FEEDING BEHAVIOR OREGON HEALTH & SCIENCE UNIVERSITY 2008-09-04 US disclosed
US-20050015820-A1 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-01-20 US disclosed
EP-1119543-B1 N-ARALKYLAMINOTETRALINS AS LIGANDS FOR THE NEUROPEPTIDE Y Y5 RECEPTOR ORTHO MCNEIL PHARM INC (US) 2004-12-15 EP disclosed
US-6201025-B1 FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS ORTHO-MCNEIL PHARMACEUTICAL, INC. 2001-03-13 US disclosed